The document is a table outlining potential newsflow and catalysts for GlaxoSmithKline in 2015 and 2016, including events such as patent expiries, regulatory decisions, and trial results.
documents/vol00010-efta01457560-pdf.pdf
{"title":"Potential newsflow and catalysts","document_date":"May 2015","document_type":"tabular","key_locations":["London"],"document_subtype":"newsflow and catalysts table","key_organizations":["GlaxoSmithKline","Deutsche Bank"],"reference_numbers":["DB-SDNY-0117157","SDNY_GM_00263341","EFTA01457560"]}